Alvogen Lux Holdings acquired 95,000 shares in Alvotech at ISK 1,260 each on May 20, 2025.
Quiver AI Summary
The press release announces that Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech, has acquired 95,000 shares at a price of ISK 1,260 per share on May 20, 2025. This transaction was filed with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) and highlights that Alvogen Lux Holdings' major shareholders include CVC (40%), Aztiq (30%), and Temasek (20%).
Potential Positives
- Alvogen Lux Holdings has increased its stake in Alvotech by acquiring 95,000 shares, indicating confidence in the company's future performance.
- This acquisition reinforces Alvogen Lux Holdings' position as the second largest shareholder in Alvotech, which may enhance their influence over corporate decisions.
- By purchasing shares at ISK 1,260, the transaction may reflect perceived value and potential growth, which could positively affect market perception of Alvotech.
Potential Negatives
- The announcement of the acquisition of shares by a closely associated entity may raise concerns regarding potential conflicts of interest, as it involves significant stakeholders in Alvotech.
- The timing of the share acquisition could lead to speculation about the performance or outlook of Alvotech, potentially undermining investor confidence.
- The dependency on a limited number of large shareholders (CVC, Aztiq, and Temasek) may pose risks regarding decision-making power and stability for Alvotech, highlighting a lack of diversification in its investor base.
FAQ
Who acquired 95,000 shares in Alvotech?
Alvogen Lux Holdings S.ár.l. acquired 95,000 shares in Alvotech.
What was the acquisition price per share for Alvotech?
The acquisition price was ISK 1,260 per share.
When did the transaction for Alvotech shares take place?
The transaction occurred on May 20, 2025.
Who are the major shareholders of Alvogen Lux Holdings?
The major shareholders are CVC (40%), Aztiq (30%), and Temasek (20%).
Where was the acquisition filed?
The acquisition was filed with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF).
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ALVO Hedge Fund Activity
We have seen 27 institutional investors add shares of $ALVO stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,401,421 shares (+inf%) to their portfolio in Q1 2025, for an estimated $13,551,741
- VANGUARD GROUP INC added 995,538 shares (+31.1%) to their portfolio in Q1 2025, for an estimated $9,626,852
- SCULPTOR CAPITAL LP removed 565,359 shares (-93.3%) from their portfolio in Q1 2025, for an estimated $5,467,021
- MORGAN STANLEY removed 469,680 shares (-31.7%) from their portfolio in Q1 2025, for an estimated $4,541,805
- POINTSTATE CAPITAL LP removed 67,040 shares (-5.4%) from their portfolio in Q1 2025, for an estimated $648,276
- OAKTREE CAPITAL MANAGEMENT LP removed 57,222 shares (-3.0%) from their portfolio in Q1 2025, for an estimated $553,336
- FREEGULLIVER LLC removed 43,681 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $577,899
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 95,000 shares in Alvotech at ISK 1,260 per share, by Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech. The date of the transaction is May 20, 2025. Alvogen Lux Holdings' largest shareholders are CVC (40%), Aztiq (30%) and Temasek (20%).
Attachment
